On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...